Recent investigations involving 656 patients with morbid obesity without diagnosed diabetes have indicated that 1hPG levels ≥8.6 mmol/L may be effective in identifying a more severe metabolic disturbance, characterized by elevated glycemic levels, reduced insulin sensitivity, and significantly impaired β-cell function [26]. The gene discussed is INS; the disease is morbid obesity.